Provided by Tiger Trade Technology Pte. Ltd.

Pacific Biosciences of California

1.84
0.0000
Post-market: 1.840.00000.00%19:58 EST
Volume:9.52M
Turnover:17.36M
Market Cap:555.51M
PE:-1.08
High:1.92
Open:1.85
Low:1.76
Close:1.84
52wk High:2.73
52wk Low:0.8511
Shares:301.91M
Float Shares:298.17M
Volume Ratio:1.47
T/O Rate:3.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7058
EPS(LYR):-1.1288
ROE:-205.90%
ROA:-32.23%
PB:15.39
PE(LYR):-1.63

Loading ...

Pacific Biosciences Q4 Adj. EPS $(0.12) Beats $(0.15) Estimate, Sales $44.645M Beat $42.530M Estimate

Benzinga
·
6 hours ago

PacBio Q4 revenue rises 14% driven by strong consumable sales

Reuters
·
6 hours ago

PacBio Q4 Vega system placements surge to 42 units, up 6x year-on-year

Reuters
·
6 hours ago

BRIEF-Pacific Biosciences of California Q4 Adjusted Net Income USD -37.6 Million Vs. IBES Estimate USD -44.3 Million

Reuters
·
6 hours ago

Pacific Biosciences of California Q4 Adjusted Gross Profit USD 17.8 Million

THOMSON REUTERS
·
6 hours ago

Pacific Biosciences of California Inc Qtrly Adj EPS $-0.12

THOMSON REUTERS
·
6 hours ago

PacBio Joins iHope Initiative to Advance Long-Read Genomic Sequencing for Rare Disease

Reuters
·
Yesterday

Pacific Biosciences Shifts Key Executive Responsibilities in Leadership Reshuffle

Reuters
·
Feb 04

Pacific Biosciences of California Closes $48.1 Million Sale of DNA Sequencing Assets to Illumina

MT Newswires Live
·
Feb 02

Pacific Biosciences of California Inc - Received $48.1 Mln in Net Cash Proceeds

THOMSON REUTERS
·
Feb 02

Pacbio Completes Sale of Short-Read Sequencing Assets

THOMSON REUTERS
·
Feb 02

Press Release: PacBio Completes Sale of Short-Read Sequencing Assets

Dow Jones
·
Feb 02

Pacific Biosciences of California Inc. to Report Fourth Quarter and Full Year 2025 Financial Results

Reuters
·
Jan 28

PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026

GlobeNewswire
·
Jan 28

PacBio to Collaborate With n-Lorem Foundation and EspeRare on Precision Therapies for Rare Diseases

Reuters
·
Jan 12

PacBio Reports Preliminary 2025 Revenue of $160 Million with 4% Year-Over-Year Growth

Reuters
·
Jan 12

PacBio HiFi Sequencing Adopted as First-Line Tool for SUDC Research

Reuters
·
Jan 12

Pacific Biosciences of California Inc - Announces Prelim Q4 2025 Revenue of $44.6 Mln

THOMSON REUTERS
·
Jan 12

Pacbio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue

THOMSON REUTERS
·
Jan 12

PacBio Unveils CiFi Method for Chromosome-Scale Genome Assemblies in Single Sequencing Run

Reuters
·
Jan 08